Faeth Therapeutics
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- $91M
Investors
- 10
About Faeth Therapeutics
a. Faeth, operates as a clinical-stage biotechnology company that develops nutrition solutions for battling cancer among patients. In October 2025, Faeth Therapeutics, Inc. Faeth operates a learning-driven preclinical discovery platform called MetabOS which identifies the impact of tumors based on genotype, organ of origin, and therapy. Patients are onboarded into a highly personalized precision nutrition program combining meals, therapeutics, and advice from a tea of dieticians. The meals are delivered to the patient's door. The company's team consists of high-profile scientists including Lew Cantley, director of the Meyer Cancer Center at Weill Cornell Medicine and Sid Mukherjee, an oncologist at Columbia University Irving Medical Center. Faeth Therapeutics generates revenue through clinical-stage oncology programs, precision nutrition services, and its MetabOS platform, combining drug therapies with metabolic optimization for cancer treatment.
Who invested in Faeth Therapeutics
10 investors across 5 rounds
See all investors in Faeth Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Faeth Therapeutics
Who invested in Faeth Therapeutics?
Faeth Therapeutics has 10 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Faeth Therapeutics raised?
Faeth Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Faeth Therapeutics last raise money?
Faeth Therapeutics's most recent round on record is a Series A, in Oct 2025.
What does Faeth Therapeutics do?
Faeth Therapeutics is a biotechnology company.
Where is Faeth Therapeutics headquartered?
Faeth Therapeutics is headquartered in Austin, US.
Which VCs invest in companies like Faeth Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Faeth Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Faeth Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.